Diseases & Disorders
(G300)
DX Registered
990 on File
AMERICAN CANCER SOCIETY INC
Financial strength (30%)
72/100
Reliability (20%)
70/100
Effectiveness (25%)
78/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$136.8M
Total Revenue
$166.6M
Total Expenses
$1233.4M
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
77.0%
Fundraising Efficiency
458.1%
Operating Reserve
88.82x
Liability-to-Asset
25.4%
Revenue Diversification
90.4%
Executive Compensation
$665K
Compared with Peers
FY 2025
Compared with 15 similar organizations
(United States, Diseases & Disorders, $100M and over in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
77.0% | 83.5% |
P10P90
|
Below median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
4.9% | 8.8% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
18.1% | 10.7% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
458.1% | 567.2% |
P10P90
|
Above median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
88.8 mo | 9.5 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
25.4% | 29.1% |
P10P90
|
Above median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
90.4% | 91.8% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
-81.1% | 5.7% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-79.0% | 4.9% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-21.8% | 0.0% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $136.8M | $166.6M | $1233.4M | 77.0% | 0 |
| 2024 | $724.2M | $791.9M | $1295.9M | 79.8% | 3348 |
| 2023 | $656.8M | $756.3M | $1278.4M | 79.4% | 3300 |
| 2022 | $674.5M | $669.2M | $1255.2M | 81.1% | 3153 |
| 2021 | $734.4M | $577.7M | N/A | — | 2940 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.